1st Mar 2016 11:15
LONDON (Alliance News) - Biopharmaceutical company PuriCore PLC on Tuesday said it has appointed Balkrishan Gill as a non-executive director with immediate effect.
Gill is the chief executive of Evelo Biosciences, which is developing microbiome-based therapies for cancer, and executive chairman of Blackfynn Inc, a neurology data management and analytics firm.
PuriCore shares were untraded Tuesday, having last traded at 23.61 pence.
By Sam Unsted; [email protected]; @SamUAtAlliance
Copyright 2016 Alliance News Limited. All Rights Reserved.
Related Shares:
PURI.L